Bioprosthetics Market Size, Share & Trends Analysis Report By Product (Allograft, Xenograft), By Application (Cardiovascular, Plastic Surgery & Wound Healing), By Region, And Segment Forecasts, 2024

Description

Bioprosthetics Market Growth & Trends:

The global bioprosthetics market size is expected to reach USD 7.6 billion by 2030, registering to grow at a CAGR of 4.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Bioprosthetics Market Report Highlights:

The allograft segment is expected to exhibit growth at a significant CAGR during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia
The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 9.6% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction
Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments
In 2023, Europe dominated the overall bioprosthetics market. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region
For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe
Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion

Product Code: 978-1-68038-980-7

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Bioprosthetics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Bioprosthetics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Bioprosthetics Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Bioprosthetics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Allograft
- 4.3.1. Allograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Xenograft
- 4.4.1. Xenograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Porcine
  - 4.4.2.1. Porcine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Bovine
  - 4.4.3.1. Bovine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioprosthetics Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Bioprosthetics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Cardiovascular
- 5.3.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Plastic Surgery & Wound Healing
- 5.4.1. Plastic Surgery & Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 6. Bioprosthetics Market: Regional Estimates & Trend Analysis

6.1. Bioprosthetics Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
- 6.2.1. North America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. U.K.
  - 6.3.2.1. U.K. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
  - 6.3.5.1. Italy Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
  - 6.3.6.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
  - 6.3.8.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
  - 6.3.9.1. Norway Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Japan
  - 6.4.2.1. Japan Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. China
  - 6.4.3.1. China Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. Australia
  - 6.4.5.1. Australia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. South Korea
  - 6.4.6.1. South Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
  - 6.6.2.1. South Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. Saudi Arabia
  - 6.6.3.1. Saudi Arabia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. UAE
  - 6.6.4.1. UAE Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. LeMaitre Vascular, Inc.
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Braile Biomedica
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Labcor Laboratorios Ltda
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Medtronic
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Rua Life Sciences Plc (Aortech International Plc.)
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. LivaNova PLC (Sorin Group)
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Organogenesis Inc.
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Humacyte Global, Inc.
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Johnson & Johnson (Ethicon, Inc.)
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.10. Artivion, Inc. (CryoLife, Inc.)
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiatives
- 7.4.11. Abbott (St. Jude Medical, Inc.)
  - 7.4.11.1. Participant's Overview
  - 7.4.11.2. Financial Performance
  - 7.4.11.3. Product Benchmarking
  - 7.4.11.4. Recent Developments/ Strategic Initiatives
- 7.4.12. Edwards Lifesciences Corporation.
  - 7.4.12.1. Participant's Overview
  - 7.4.12.2. Financial Performance
  - 7.4.12.3. Product Benchmarking
  - 7.4.12.4. Recent Developments/ Strategic Initiatives
- 7.4.13. JenaValve
  - 7.4.13.1. Participant's Overview
  - 7.4.13.2. Financial Performance
  - 7.4.13.3. Product Benchmarking
  - 7.4.13.4. Recent Developments/ Strategic Initiatives

Bioprosthetics Market Size, Share & Trends Analysis Report By Product (Allograft, Xenograft), By Application (Cardiovascular, Plastic Surgery & Wound Healing), By Region, And Segment Forecasts, 2024 - 2030